← Evidence map

TrialInternational journal of clinical pharmacology and therapeutics2022

Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life.

Madhu Sanga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Randomized, double-blind, two-way crossover bioequivalence and adhesion study, in healthy women, of a transdermal contraceptive patch with a newly sourced adhesive component at the end of shelf life vs. the EVRA patch at the beginning of shelf life. | OpenQuestion